SCHEMBL30990222

SCHEMBL30990222

COc1ccc(CSc2c[nH]c3cc(C(=O)O)sc23)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FFAR1 O14842 1/20 0.47
▸ DAO P14920 1/20 0.46
▸ TP53 P04637 2/20 0.43
▸ CYP1A2 P05177 1/20 0.42
▸ CYP2E1 P05181 1/20 0.42
▸ CYP3A4 P08684 1/20 0.42
▸ CYP2C8 P10632 1/20 0.42
▸ CYP2D6 P10635 1/20 0.42
▸ CYP2C9 P11712 1/20 0.42
▸ CYP2B6 P20813 1/20 0.42
▸ CYP2C19 P33261 1/20 0.42
▸ CA12 O43570 1/20 0.40
▸ CA1 P00915 1/20 0.40
▸ CA2 P00918 1/20 0.40
▸ CA9 Q16790 1/20 0.40
▸ MAPT P10636 4/20 0.39
▸ GAA P10253 1/20 0.39
▸ MAOA P21397 1/20 0.38
▸ MAOB P27338 1/20 0.38
▸ MEN1 O00255 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10687383 0.68 APP (0.58) FFAR1DAOTP53CYP3A4CA12
SCHEMBL16903488 0.68 FFAR1 (0.55) FFAR1DAOTP53CYP1A2CYP2E1
SCHEMBL6290570 0.67 RAB9A (0.67) FFAR1TP53CYP1A2MAPTMEN1
SCHEMBL30990200 0.67 DAO (0.43) DAOTP53CYP1A2CYP2E1CYP3A4
SCHEMBL20644280 0.67 FFAR1 (0.57) FFAR1TP53CYP1A2CYP2E1CYP3A4
SCHEMBL17124874 0.67 FFAR1 (0.54) FFAR1TP53CYP1A2CYP2E1CYP3A4
SCHEMBL17080124 0.66 KDM4E (0.52) FFAR1DAOTP53CYP1A2CYP2D6
SCHEMBL17080148 0.66 KDM4E (0.56) FFAR1DAOTP53CYP1A2CYP2D6
SCHEMBL11826469 0.66 FFAR1 (0.47) FFAR1DAOTP53CYP1A2CYP2E1
SCHEMBL30786144 0.66 FFAR1 (0.47) FFAR1DAOTP53CYP1A2CYP2E1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4626860-A1 FUSED PYRROLYL-SULFONAMIDE COMPOUNDS ReWind Therapeutics NV (BE) 2025-10-08 — — EP disclosed
WO-2024115733-A1 FUSED PYRROLYL-SULFONAMIDE COMPOUNDS REWIND THERAPEUTICS NV (BE) 2024-06-06 — — WO disclosed
Send feedback